No. 84 of 500 No. 6 in AI by Industry

Super Agers

An Evidence-Based Approach to Longevity

By Eric Topol

Published
May 6, 2025
Print length
464 pages
Reading level
Beginner
ISBN-13
978-1668067666
Publisher
Simon & Schuster
Written for
Health-conscious adults, clinicians and health-tech professionals interested in AI-enabled, evidence-based disease prevention.

Synopsis

Eric Topol, a cardiologist and genomic-medicine researcher at Scripps Research, starts from his team's study of about 1,400 people who reached their eighties or beyond without major chronic disease, and from the finding that their genes explained surprisingly little of their good health. He then explains why the three great age-related killers, cardiovascular disease, cancer and neurodegeneration, develop over two decades or more before symptoms appear, which leaves a long window for prevention. Chapters cover the biology of aging, epigenetic and protein-based organ clocks that show whether one organ is aging faster than the rest, chronic inflammation, the immune system as a missing layer of medical data, and GLP-1 drugs.

Topol's prescription has two halves. The first is a lifestyle program he calls Lifestyle Plus, which adds environmental exposures such as air pollution, microplastics and forever chemicals, along with social isolation and time in nature, to the familiar trio of diet, exercise and sleep. The second is precision prevention, in which multimodal AI combines polygenic risk scores, organ clocks and blood biomarkers such as p-tau217 for Alzheimer's risk to identify high-risk people years ahead. He separates published evidence from longevity hype throughout. Readers gain a practical, sourced plan and a realistic sense of which AI-enabled tests are close to routine use and which remain research tools.

Scorecard

Editorial score

How it scored

Editorial score: 81.5 / 1005 weighted criteria

  • Influence30%

    22.5/30
  • Authority25%

    22.5/25
  • Practical value20%

    16.0/20
  • Currency15%

    13.5/15
  • Readability10%

    7.0/10
  • Editorial score

    81.5/100

How the rank was computed

Rank No. 84 of 500 comes from a composite of 64.2: observable signals 27.5 of 55 points plus editorial review 36.7 of 45 points.

All 11 inputs
InputPoints
Observable signals27.5/55
Reach (Amazon ratings volume)11.1/16.5
Consensus across best-of lists2.8/13.8
Awards and bestseller evidence3.3/8.3
Reader rating, sample-adjusted5.5/8.3
Amazon sales rank2.0/5.5
Recency2.8/2.8
Editorial review36.7/45
Author authority10.1/11.3
Influence10.1/13.5
Practical value7.2/9.0
Readability3.2/4.5
Currency6.1/6.8

Each criterion is scored from 1 to 10 and weighted, and the points add up to the editorial score. The rank combines observable signals (55 percent) with this score (45 percent). Read the methodology.

Verdict

A rigorous, evidence-first guide to healthy aging that treats AI as one tool among many for predicting and preventing chronic disease.

Strengths

  • Author ranks among medicine's most cited researchers
  • Separates published evidence from longevity hype
  • Concrete, actionable prevention guidance for readers

Keep in mind

AI is one thread among many rather than the focus, and the immunology chapters can be technically dense for lay readers.

Key takeaways

  1. Heart disease, cancer and neurodegeneration develop over 20 years or more before symptoms, so prevention can begin decades ahead of diagnosis.
  2. Organ clocks derived from blood proteins can reveal whether a specific organ, such as the heart or brain, is aging faster than the rest of the body.
  3. Multimodal AI that combines polygenic risk scores, organ clocks and blood biomarkers could flag high-risk individuals early enough for targeted prevention.
  4. Low-cost habits, including exercise, sleep, diet, social connection, time in nature and reduced exposure to pollutants and microplastics, remain the foundation of healthy aging.

Notable facts

About the author

Eric Topol

Eric Topol is executive vice president of Scripps Research, founder and director of the Scripps Research Translational Institute, and a practicing cardiologist. Elected to the National Academy of Medicine in 2004, he has published more than 1,300 peer-reviewed articles and ranks among the ten most cited researchers in medicine. His earlier books include Deep Medicine, on how artificial intelligence can make healthcare human again.

Questions

What role does AI play in Super Agers?
AI is a supporting theme rather than the book's main subject. Topol argues that multimodal AI can combine polygenic risk scores, organ clocks derived from blood proteins and biomarkers such as p-tau217 to flag people at high risk of heart disease, cancer or Alzheimer's years before symptoms. Most of the book covers the biology of aging, inflammation, immunity, drugs and lifestyle.
Is Super Agers evidence-based or another longevity fad book?
It is evidence-based. Topol, a cardiologist and one of medicine's most cited researchers, grounds his claims in published studies, including his team's research on about 1,400 healthy people aged 80 and older, and he separates proven interventions from speculative longevity products. Reviewers have praised its rigor, though one reviewer found its coverage broad but shallow.
Who should read Super Agers?
Adults in midlife or later who want a science-based plan for staying healthy will benefit most, along with clinicians and health-technology professionals tracking prevention and precision medicine. Readers who want a book focused on artificial intelligence itself should start with Topol's Deep Medicine, since Super Agers treats AI as one tool within a broader program of prevention.

Sources

As an Amazon Associate, Best AI Books earns from qualifying purchases. Best AI Books is sponsored by Iternal.ai, whose founder and CEO, John Byron Hanby IV, wrote The AI Strategy Blueprint, our #1 ranked book. How we rank books.